Julio Figueroa

Professor, LSUHSC Section of Infectious Diseases; Love clinical microbiology, antibiotic stewardship, and general infectious diseases; New Orleanian

[Mike Hoerger, PhD MSCR MBA @michael_hoerger]

Police removed diabetes scientists from the convention center here in New Orleans today after they attempted to pass out copies of an editorial from a peer-reviewed scientific journal (impact factor = 16.6) that was critical of NIH.

[Carlos del Rio @CarlosdelRio7]

Misguided Brushes of a Pen Continue to Dismantle and Destroy Biomedical Research in the United States: We Can No Longer Afford Complacency and Fear. We Must All Act Now! Make sure you read and disseminate the editorial in Diabetes Care. https://t.co/ITI9bwDpQn

[IDSA @IDSAInfo]

On IDSA’s & @HIVMA’s Science Speaks blog: Learn about the effectiveness of the MMR vaccine in a contemporary outbreak setting in the U.S., rhinovirus as a dual respiratory tract pathogen and other research ready to inform clinical practice. https://t.co/yQ6vMvKt28

[IDSA @IDSAInfo]

“We can provide supportive care, but we do not have effective antiviral therapy once someone gets severe measles.”

IDSA spokesperson Ruth Lynfield, MD, FIDSA, discusses the realities of severe #measles infections in our latest press briefing: https://t.co/DGKtqgj8dI

[IDSA @IDSAInfo]

ID fellows: Join us for the next Fellows Case Conference on Monday, June 15 at 2pm ET. Explore a unique ID case alongside presenters Jonathan Huang, MD, and Melissa Kerkelis, MD, with faculty discussants Alex Zimmet, MD, and Courtney Harris, MD.

Register: https://t.co/MFpxOC4TXq

[Clinical Infectious Diseases @CIDJournal]

The Best of Both Worlds: How Combining a Large Language Model and a Rule-Based Algorithm Makes CAUTI Surveillance More Efficient

✅ Just Accepted
https://t.co/IDcfibFbk4

[Brad Spellberg @BradSpellberg]

One of the most confusing aspects of antibiotic resistance is the distinction between ecological resistance and clinical resistance. Clinical resistance is a construct based on CLSI breakpoints. We would all like to think those are based on clinical data but we know they are not.

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Pseudomonas sparing’ antibiotics, is it time to rethink this notion?
🆕💥🟢Study
Prolonged in vitro exposure of P. aeruginosa to subinhibitory concentrations of antibiotics lacking intrinsic antipseudomonal activity (Ceftriaxone,moxi,Erta) selects for stable,heritable resistance to antipseudomonal agents #idxposts https://t.co/xcJcYfa9ci

[Nico Merchante @nicomerchante]

Seven days is not inferior (and better!!) to 14 days for the treatment of Pseudomonas aeruginosa bacteremia @shorten2trial presented at @SEIMC_

Amazing work led by @josemolinagb and Jose Miguel Cisneros 🙌🏻

@ABsteward @BradSpellberg
@ProaValme @guiaprioam

[Open Forum Infectious Diseases @OFIDJournal]

Clinical Impact of Linezolid Therapeutic Drug Monitoring on the Tolerability of Prolonged Courses in the Outpatient Setting

✅ Just Accepted
🔗 https://t.co/j2SihrzJFW

[Carlos del Rio @CarlosdelRio7]

Characteristics of Patients Hospitalized with Measles During an Outbreak — West Texas, January–March 2025 https://t.co/YHdskNdiZF 325 cases were reported & 60 hospitalized. All hospitalized were unvaccinated, 91% were <18 years and one died.

[Jeanne Marrazzo @DrJeanneM]

Could not say this more eloquently and given that @KrutikaKuppalli has lived through it we should listen. Americans deserve better @IDSAInfo

[IDSA @IDSAInfo]

“Policies that single out individuals, not for any scientific or medical reason, but because of their citizenship, won’t prevent outbreaks from spreading,” says IDSA CEO @DrJeanneM.

Watch our latest press briefing on the active #Ebola outbreak: https://t.co/HMB9me5tnd

[IDSA @IDSAInfo]

“Investing in global health preparedness, supporting international coordination through organizations like WHO and strengthening local health systems are not acts of charity,” stresses IDSA spokesperson @KrutikaKuppalli.

Watch our new press briefing: https://t.co/HMB9me5tnd

[IDSA @IDSAInfo]

The reported departure of leadership at NIAID, the dismissal of scientific leaders from the U.S. Preventive Services Task Force and the lack of permanent leadership at CDC endangers everyone.

Our statement with @HIVMA, @PIDSociety, @SHEA_Epi, @SIDPharm: https://t.co/Pqi9CJy2wa

[Julio Figueroa @jfigue]

100%

[IDSA @IDSAInfo]

It’s #IDPharmacistsDay! Today we recognize the vital role ID pharmacists play in patient care, research, and stewardship.

IDSA is proud to be the professional home for ID and to expand opportunities for pharmacists to engage, connect, and lead.

[IDSA @IDSAInfo]

ID Pharmacists play an essential role in health systems. This #IDPharmacistsDay, learn five ways that pharmacists are being #AntibioticsAware via @SIDPharm.

For more sharable resources, visit https://t.co/dOX77jwYED.

[IDSA @IDSAInfo]

Today, IDSA PPAC Chair @ClancyNeil spoke at an AMR Action Fund briefing on the need to invest in antimicrobial R&D, stewardship and the ID workforce to protect patients with cancer from resistant infections.

Urge your rep to cosponsor the PASTEUR Act: https://t.co/verWEhc7Ma

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕💥🟢A contaminated dicloxacillin capsules in Europe triggered not only a clonal NDM-5/OXA-48 Enterobacter hormaechei outbreak, but also plasmid transfer to other Enterobacterales.
Many cases were missed by standard strain-based outbreak methods #idxposts
https://t.co/ufFRTsCEF0

[Jeanne Marrazzo @DrJeanneM]

Worrisome if not unexpected development re #ebolavirus